Drug Type Peptide Conjugate Radionuclide, Therapeutic radiopharmaceuticals |
Synonyms- |
Target |
Action antagonists |
Mechanism FAP antagonists(Fibroblast activation protein alpha antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Adenomatous Polyposis Coli | Phase 1 | China | 21 Aug 2024 | |
Advanced cancer | Phase 1 | China | 21 Aug 2024 | |
Neoplasm Metastasis | Phase 1 | China | 21 Aug 2024 | |
Neoplasms | Preclinical | China | 29 Apr 2025 |